VantagePoint A.I. Stock of the Week Arrowhead Pharmaceuticals ($ARWR)
Wall Street’s got 11 analysts throwing darts at Arrowhead, and the “average” target is $36. Big whoop. The real story isn’t the middle number — it’s the gap between the bulls and the bears. One camp says this thing can run to $80, the other swears it’s worth only $12. That’s a $68 spread on a $34 stock. Let that sink in. These aren’t bored Reddit posters guessing in between Monster Energy chugs — these are professionals who live and breathe this company, comb through every line of every filing, and still come out with forecasts that look like they’re describing two completely different planets. That variance is the proof in the pudding.